Search Results - "Rahmat, Leena"

  • Showing 1 - 14 results of 14
Refine Results
  1. 1

    Venetoclax in Combination with Decitabine for Relapsed T-Cell Acute Lymphoblastic Leukemia after Allogeneic Hematopoietic Cell Transplant by Logan, Aaron C., Prakash, Sonam, Abdulhaq, Haifaa, Nguyen, Anna, Rahmat, Leena T., Mannis, Gabriel N.

    Published in Case reports in hematology (01-01-2018)
    “…Long-term disease-free survival in adults with T-cell acute lymphoblastic leukemia (T-ALL) remains poor, particularly after relapse, with few available salvage…”
    Get full text
    Journal Article
  2. 2

    The Use of Natural Health Products Especially Papaya Leaf Extract and Dandelion Root Extract in Previously Untreated Chronic Myelomonocytic Leukemia by Rahmat, Leena T., Damon, Lloyd E.

    Published in Case reports in hematology (01-01-2018)
    “…Chronic myelomonocytic leukemia (CMML) is a clonal hematopoietic disorder which shares clinical and morphological features of myelodysplastic syndrome and…”
    Get full text
    Journal Article
  3. 3

    A Rare Oncologic Emergency: Spontaneous Tumor Lysis Syndrome in Metastatic Colon Adenocarcinoma by Kalmbach, Kathleen, Rahmat, Leena, Wos, Justyna, Daniel, Nicholas

    “…Tumor lysis syndrome is an oncologic emergency that can present with variable symptoms and is truly a laboratory-based diagnosis without pathognomonic clinical…”
    Get full text
    Journal Article
  4. 4

    A rare case of hepatosplenic gamma‐delta T‐cell lymphoma and secondary hemophagocytic lymphohistiocytosis by Brandt, Philip H., Rahmat, Leena T., Ali, Syed S.

    Published in Clinical case reports (01-01-2019)
    “…Key Clinical Message Hepatosplenic gamma‐delta T‐cell lymphoma with concurrent hemophogocytic lymphohistiocytosis is a rare but well‐recognized clinical…”
    Get full text
    Journal Article
  5. 5

    The first reported case of vincristine‐induced unilateral vocal cord palsy in an adult patient with HIV‐associated Burkitt‐like lymphoma being treated with dose‐escalated R‐EPOCH by Rahmat, Leena T., Brandt, Philip H., Ali, Syed S.

    Published in Clinical case reports (01-02-2019)
    “…Key Clinical Message Vincristine‐induced vocal cord palsy (VCP) is a rare but critical complication. Prompt recognition of VCP is imperative…”
    Get full text
    Journal Article
  6. 6

    Gilteritinib is a clinically active FLT3 inhibitor with broad activity against FLT3 kinase domain mutations by Tarver, Theodore C., Hill, Jason E., Rahmat, Leena, Perl, Alexander E., Bahceci, Erkut, Mori, Kenichi, Smith, Catherine C.

    Published in Blood advances (11-02-2020)
    “…Gilteritinib is the first FMS-like tyrosine kinase 3 (FLT3) tyrosine kinase inhibitor (TKI) approved as monotherapy in acute myeloid leukemia with FLT3…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14